The Norwegian network of drug information centres (RELIS) has achievements in person-centred and personalised medicine. RELIS receive questions from physicians, pharmacists, nurses and other health professionals and provide decision support in all aspects of pharmacotherapy. Questions associated with person-centred medicine often include problems with unrealistic risk perception and poor adherence among patients. Questions associated with personalised medicine frequently concern comorbidity, biomarkers and pharmacogenetics. The questions frequently include a mix of problems related to health and disease care. The RELIS staff addresses each question in a problem-oriented approach with expertise in pharmacology and skills in searching and critical evaluation of the literature. A written answer can describe decision support concerning patient empowerment, further diagnostics and preferences in pharmacotherapy including advice with regard to choice of drug and dose to a patient. Links to online resources and attached references for further reading are often included in the answers. The question–answer service is documented in a full-text, searchable question–answer database. Additional drug information activities towards clinicians and patients, and a multi-professional staff with pharmacists and clinical pharmacologists, are important elements in RELIS drug information strategy, and it is essentially relevant to predictive, preventive and personalised medicine (PPPM).
Database Decision support Drug information centre Multi-professional expertise Patient empowerment Person-centred medicine PPPM Risk
Drug information centres
Drug-induced liver injury
Hormone replacement therapy
Predictive, preventive and personalised medicine
Norwegian network of drug information centres
Selective serotonin reuptake inhibitors
Traditional, complementary and alternative medicine
Therapeutic drug monitoring
This is a preview of subscription content, log in to check access.
Compliance with ethical standards
Conflict of interest
The author declares that he has no competing interests.
Alván G, Öhman B, Sjöqvist F. Problem-oriented drug information: a clinical pharmacological service. Lancet. 1983;322(8364):1410–2.CrossRefGoogle Scholar
Schjøtt J, Pomp E, Gedde-Dahl A. Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians? Eur J Clin Pharmacol. 2002;57(12):897–902.CrossRefGoogle Scholar
Schjøtt J, Reppe LA, Roland PD, Westergren T. A question-answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study. BMJ Open. 2012;2(2):e000642. https://doi.org/10.1136/bmjopen-2011-000642.CrossRefGoogle Scholar
Golubnitschaja O, Watson ID, Topic E, Sandberg S, Ferrari M, Costigliola V. Position paper of the EPMA and EFCCLM: a global vision of the consolidated promotion of an integrative medical approach to advance healthcare. EPMA J. 2013;4(1):12. https://doi.org/10.1186/1878-5085-4-12.CrossRefGoogle Scholar
Schjøtt J, Erdal H. Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study. BMC Complement Altern Med. 2014;14(56). https://doi.org/10.1186/1472-6882-14-56.
Golubnitschaja O, Costigliola V, EPMA. General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European association for predictive, preventive and personalised medicine. EPMA J. 2012;3:14. https://doi.org/10.1186/1878-5085-3-14.CrossRefGoogle Scholar